Skip to main content

Table 2 Bivariable and multivariable GEE analyses to estimate the relationship between OAT dissatisfaction and fentanyl exposure

From: The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting

Variable

Any OAT

Restricted to Methadone

 

OR (95% CI)

AOR (95% CI)

OR (95% CI)

AOR (95% CI)

OAT dissatisfaction

1.20 (1.00–1.44)

1.34 (1.08–1.66)

1.30 (1.07–1.58)

1.47 (1.16–1.87)

Age (per year increase)

0.94 (0.93–0.96)

0.95 (0.94–0.97)

0.94 (0.92–0.95)

0.95 (0.93–0.96)

Male gender

0.89 (0.68–1.15)

 

0.86 (0.64–1.15)

 

White

1.12 (0.86–1.45)

 

1.04 (0.78–1.40)

 

Homelessnessa

1.87 (1.38–2.53)

1.31 (0.93–1.84)

1.94 (1.37–2.75)

1.44 (0.97–2.13)

 ≥ Daily stimulant usea,b

1.20 (0.96–1.50)

 

1.20 (0.93–1.56)

 

Injection drug usea

4.49 (3.47–5.82)

4.23 (3.25–5.52)

4.49 (3.37–5.99)

4.24 (3.15–5.71)

Most recent OAT = methadone

0.92 (0.71–1.20)

 

NA

NA

  1. AOR adjusted odds ratio, CI confidence interval, OR odds ratio, OAT opioid agonist therapy
  2. aDenotes behaviours/events in the past 6 months
  3. bRefers to any route of consumption (i.e., sniffing, snorting, smoking or injecting)